SUN Pharma Canada Inc. Pharmaceutical Import Profile — Canada (DGFT 2022–2026)

Name: SUN Pharma Canada Inc. Pharmaceutical Import Records from India — 8 Products, $8.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

SUN Pharma Canada Inc. — Pharmaceutical Importer Profile (2026) | 8 Products, $8.7M Trade | TransData Nexus

Who Are the Verified Indian Suppliers to SUN Pharma Canada Inc.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Sun Pharmaceutical Industries Limited	$7.1M	301	100.0%

SUN Pharma Canada Inc. sources from 1 verified Indian supplier across 187 distinct formulations. The sourcing is highly concentrated — Sun Pharmaceutical Industries Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does SUN Pharma Canada Inc. Import?

Formulation	Value	Ships
Ramipril and hydrochlorothiazide	$345.8K	12
Esomeprazole magnesium gastro	$331.1K	10
Taro-cefprozil TAB 500MG Pack: 100s	$264.2K	6
Taro apixaban TAB 5MG cd 60btl (30404	$150.0K	3
Taro apixaban TAB 5MG cd 180btl (20196	$150.0K	3
Taro apixaban tablets 5MG (30785 bottlex 180 tabs) batch no. apxtb2401a; apxtb2402a & apxtb2403a, mfg dt. 03/24 exp dt.	$150.0K	3
Ran-esomeprazole tablets 40MG (Each tablet contains: esomeprazole magnesium equivalent to 40MG) [6366 Pack x 100's	$150.0K	3
Taro apixaban tablets 5MG [10053 Pack	$100.0K	2
Taro-cefprozil TAB 250MG Pack: 100s	$100.0K

SUN Pharma Canada Inc. imports 187 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

What Products Does SUN Pharma Canada Inc. Import?

Top Products by Import Value

1Esomeprazole$4.3M 2Magnesium$1.4M 3Gliclazide$1.4M 4Ramipril$945.4K 5Omeprazole$350.0K 6Sunitinib$150.0K

Import Portfolio — Top 8 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Esomeprazole	Gastrointestinal	$4.3M	86	0.4%	2
2	Magnesium	Vitamins & Supplements	$1.4M	29	0.4%

Key Metrics

Total Import Value$8.7M

Products8

Shipments205

Categories5

CountryCanada

#1 Rankings0

Indian Suppliers1

Formulations187

Top Categories

Gastrointestinal53.2%

Vitamins & Supplements17.7%

Last updated: March 28, 2026

SUN Pharma Canada Inc. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Sun Pharma Canada Inc. is a subsidiary of Sun Pharmaceutical Industries Limited, a leading global specialty generic pharmaceutical company headquartered in Mumbai, India. Established in 1983, Sun Pharma has grown to become the largest pharmaceutical company in India and the fifth-largest specialty generic pharmaceutical company worldwide. Sun Pharma Canada Inc. operates from Brampton, Ontario, focusing on providing innovative and affordable medicines in dermatology, ophthalmology, and oncology. (lifesciencesontario.ca) The company's portfolio includes products such as Ilumya, Winlevi, Absorica LD, and Cequa, aiming to address unmet needs in the Canadian healthcare market. (lifesciencesontario.ca)

2Distribution Network

Sun Pharma Canada Inc. maintains its distribution operations from its Brampton, Ontario facility. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's global manufacturing footprint includes over 40 facilities across five continents, ensuring a robust supply chain to meet the needs of the Canadian market. This extensive network supports the efficient distribution of pharmaceutical products throughout Canada.

Industry Role

Supplier Relationship Intelligence — SUN Pharma Canada Inc.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Sun Pharma Canada Inc. exhibits a high degree of supplier concentration, sourcing 100% of its imported pharmaceutical formulations from Sun Pharmaceutical Industries Limited. This single-source dependency indicates a strategic choice to leverage the parent company's extensive manufacturing capabilities and established product portfolio. The stability of this relationship is evidenced by the consistent importation of 205 shipments over the 2022-2026 period, reflecting a reliable and ongoing partnership. However, this concentration also presents potential risks, such as exposure to supply chain disruptions or regulatory changes affecting the parent company's operations.

2Supply Chain Resilience

The resilience of Sun Pharma Canada Inc.'s supply chain is closely tied to the operations of Sun Pharmaceutical Industries Limited. With over 40 manufacturing facilities worldwide, Sun Pharma has a diversified production base that can mitigate risks associated with regional disruptions. Additionally, the company's adherence to Good Manufacturing Practices (GMP) and compliance with regulatory standards across various markets, including Canada, ensures the quality and reliability of its products. While the reliance on a single supplier may limit diversification, the robust infrastructure and regulatory compliance of Sun Pharmaceutical Industries Limited contribute to the overall resilience of the supply chain.

3Strategic Implications

The sourcing pattern of Sun Pharma Canada Inc. underscores a strategic alignment with its parent company's global operations, facilitating streamlined procurement and distribution processes. For Indian exporters, this presents an opportunity to engage with a well-established and reputable entity in the Canadian market. However, potential suppliers must meet the stringent quality and regulatory standards upheld by Sun Pharmaceutical Industries Limited to be considered for inclusion in the supply chain. Establishing a partnership would require demonstrating compliance with GMP and other relevant certifications, as well as the ability to meet the specific needs of the Canadian market.

TransData Nexus Research · Verified DGFT customs dataMar 2026

Importing Pharmaceuticals into Canada — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Canada

1Regulatory Authority & Framework

In Canada, the regulation of pharmaceutical products is overseen by Health Canada, the federal department responsible for national public health. The Food and Drugs Act and its associated regulations govern the importation, sale, and distribution of drugs in Canada. Pharmaceutical importers must obtain an Establishment Licence (EL) from Health Canada, which authorizes them to import and distribute drugs. Additionally, each drug product must have a Drug Identification Number (DIN), indicating that it has been reviewed and approved by Health Canada for safety, efficacy, and quality. (canada.ca)

2Import Licensing & GMP

To import pharmaceutical products into Canada, companies must hold an Establishment Licence (EL) issued by Health Canada. This licence permits the importation and distribution of drugs within the country. The foreign manufacturing site must be listed on the importer's EL, ensuring that the manufacturing facilities comply with Health Canada's requirements. Good Manufacturing Practices (GMP) certification is essential, as it ensures that pharmaceutical products are consistently produced and controlled according to quality standards. Recognized GMP certifications include those from the European Union (EU GMP), World Health Organization (WHO GMP), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must verify that their suppliers hold valid GMP certifications from recognized authorities to maintain compliance with Canadian regulations. (canada.ca)

3Quality & Labeling

Imported pharmaceutical products must undergo batch testing to confirm their quality, safety, and efficacy before being distributed in Canada. Stability studies are required to ensure that products maintain their intended quality throughout their shelf life under various storage conditions. Labeling requirements include providing information in both English and French, the official languages of Canada, to ensure accessibility and comprehension for all consumers. Serialization mandates may apply to facilitate traceability and prevent counterfeit products from entering the supply chain, enhancing patient safety and product integrity.

4Recent Regulatory Changes

Between 2024 and 2026, Health Canada has implemented several policy changes affecting pharmaceutical imports. These include updates to the Special Access Programme (SAP), which allows healthcare practitioners to request access to drugs not yet authorized for sale in Canada. Additionally, there have been revisions to the requirements for Establishment Licences and Drug Identification Numbers (DINs), aiming to streamline the approval process and enhance regulatory oversight. Importers must stay informed about these changes to ensure ongoing compliance with Canadian regulations. (canada.ca)

TransData Nexus Research · Canada regulatory databasesMar 2026

Seller's Guide — How to Become a Supplier to SUN Pharma Canada Inc.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Sun Pharma Canada Inc., provided they can meet the stringent quality and regulatory standards required by Health Canada and Sun Pharmaceutical Industries Limited. Potential suppliers should possess valid GMP certifications from recognized authorities such as the EU, WHO, or PIC/S. Additionally, demonstrating the ability to supply high-quality finished pharmaceutical formulations that align with the therapeutic areas of interest to Sun Pharma Canada Inc. will enhance the prospects of establishing a successful partnership.

2Requirements & Qualifications

Indian exporters seeking to supply Sun Pharma Canada Inc. and the Canadian market must obtain GMP certifications from recognized authorities, including the European Union (EU GMP), World Health Organization (WHO GMP), or the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Additionally, compliance with Health Canada's regulations, including obtaining an Establishment Licence and ensuring that foreign manufacturing sites are listed on the importer's licence, is essential. Products must also meet Health Canada's requirements for Drug Identification Numbers (DINs) and adhere to labeling standards in both English and French. (canada.ca)

3How to Approach

To establish a relationship with Sun Pharma Canada Inc., potential suppliers should first ensure compliance with Health Canada's regulatory requirements, including obtaining GMP certifications from recognized authorities. Engaging in direct communication with Sun Pharma Canada Inc. to understand their specific product needs and quality expectations is crucial. Participating in relevant industry conferences and forums can provide opportunities to network and showcase capabilities. Developing a comprehensive regulatory filing strategy that aligns with Canadian standards and timelines will facilitate the approval process. Patience and persistence are essential, as establishing a partnership may require navigating complex regulatory landscapes and demonstrating consistent product quality.

TransData Nexus Research · Industry procurement practicesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Matching: SUN Pharma Canada Inc. identified across shipments using consignee name normalization, aggregating 2 name variants.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
3.Market Share: Calculated per product as SUN Pharma Canada Inc.'s capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 205 individual customs records matching SUN Pharma Canada Inc..
5.Supplier Verification: SUN Pharma Canada Inc. sources from 1 verified Indian suppliers across 187 formulations, confirmed from customs records.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

8 Products Tracked

5 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

SUN Pharma Canada Inc.

SUN Pharma Canada Inc. — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to SUN Pharma Canada Inc.?

What Formulations Does SUN Pharma Canada Inc. Import?

What Products Does SUN Pharma Canada Inc. Import?

Top Products by Import Value

Import Portfolio — Top 8 by Import Value

Key Metrics

Top Categories

SUN Pharma Canada Inc. — Corporate Profile & Information

1Company Overview

2Distribution Network

Industry Role

SUN Pharma Canada Inc. Therapeutic Categories — 5 Specializations

Indian Suppliers

Related Trade Data

Need Detailed Data?

Supplier Relationship Intelligence — SUN Pharma Canada Inc.

1Sourcing Concentration Analysis

2Supply Chain Resilience

3Strategic Implications

Importing Pharmaceuticals into Canada — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

3Quality & Labeling

4Recent Regulatory Changes

SUN Pharma Canada Inc. — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

3Market Positioning

Seller's Guide — How to Become a Supplier to SUN Pharma Canada Inc.

1Opportunity Assessment

2Requirements & Qualifications

3How to Approach

Frequently Asked Questions — SUN Pharma Canada Inc.

What products does SUN Pharma Canada Inc. import from India?

Who supplies pharmaceuticals to SUN Pharma Canada Inc. from India?

What is SUN Pharma Canada Inc.'s total pharmaceutical import value?

What therapeutic categories does SUN Pharma Canada Inc. focus on?

Get Full SUN Pharma Canada Inc. Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology